A British historian, an Italian archaeologist and an American preschool teacher have never met in person, but they share a prominent pandemic bond.
Dec 26, 2022
0
7
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
Nov 3, 2022
0
9
Rheumatoid arthritis is a chronic autoimmune disease that is associated with aberrant immune responses. In a recent analysis published in Arthritis & Rheumatology, people at risk for rheumatoid arthritis (RA) and those with ...
Oct 19, 2022
0
35
A Rutgers study points to cannabidiol (CBD), a major component of hemp and medical marijuana used to treat conditions such as chronic pain, inflammation, migraines, epilepsy, autoimmune diseases, depression, and anxiety, ...
Sep 14, 2022
0
37
One of the most difficult things about lupus, a chronic autoimmune disease, is that people who have it don't always realize it—they know something's not right, but they're not sure what. They may feel exhausted and have ...
Aug 1, 2022
0
4
Several minor cannabinoids contained in the cannabis plant "strongly inhibit" the activation of human immune cells that lead to chronic inflammation, according to physiologists at The Queen's Medical Center and University ...
Jul 19, 2022
0
12
A self-reported migraine history is associated with a higher risk for some adverse pregnancy outcomes, according to a research letter published online April 30 in the American Journal of Obstetrics & Gynecology.
Jun 3, 2022
0
4
Two separate findings by a University of Houston nationally recognized expert in systemic lupus erythematosus (SLE or lupus), a chronic autoimmune disease that affects multiple organs including the kidneys, skin, joints and ...
Jun 2, 2022
0
14
An international team of researchers has identified DNA mutations in a gene that senses viral RNA, as a cause of the autoimmune disease lupus, with the finding paving the way for the development of new treatments.
Apr 27, 2022
0
347
A team of researchers at Atara Biotherapeutics has conducted a small Phase I clinical trial of a therapeutic called ATA188 that targets Epstein-Barr infections (EBV) as a treatment for multiple sclerosis (MS). Representatives ...
